论文部分内容阅读
目的:观察中晚期结直肠癌采用中西医结合治疗的临床效果。方法:将138例患者采用数字奇偶法随机分为2组各69例,对照组予单一FOLFOX4化疗方案治疗;观察组采用中西医结合疗法治疗,在对照组化疗方案的基础上加用参苓白术散治疗。比较2组临床疗效。结果:2组临床疗效缓解率比较,差异有统计学意义(P<0.05);治疗期间,与对照组比较,观察组不良反应发生率较低,组间比较,差异有统计学意义(P<0.05);2组卡氏评分量表(KPS)评分情况比较,差异有统计学意义(P<0.05)。结论:中晚期结直肠癌采用中西医结合治疗,可使临床缓解率提高,延长患者的生存期,同时不良反应发生率降低,能改善患者预后。
Objective: To observe the clinical effect of integrative medicine in the treatment of advanced colorectal cancer. Methods: 138 patients were randomly divided into two groups by digital parity method 69 cases, the control group to a single FOLFOX4 chemotherapy; observation group using the combination of traditional Chinese and Western medicine treatment in the control group based on the combination of chemotherapy with Shenling Baizhu San treatment. The clinical efficacy of two groups were compared. Results: Compared with the control group, the incidence of adverse reactions in the observation group was lower than that in the control group (P <0.05), and there was significant difference between the two groups (P < 0.05). There were significant differences between the two groups in the Karnofsky score (KPS) score (P <0.05). Conclusion: The treatment of advanced stage colorectal cancer with integrated traditional Chinese and western medicine can improve the clinical remission rate, prolong the survival of patients, and reduce the incidence of adverse reactions, can improve the prognosis of patients.